Dr. Wolf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2 Genome Court
Room 1009
Durham, NC 27710Phone+1 919-613-5914- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1999 - 2002
- Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
- State University of New York Downstate Medical Center College of MedicineClass of 1996
Certifications & Licensure
- NC State Medical License 2016 - 2024
- IL State Medical License 2013 - 2017
- FL State Medical License 2008 - 2014
- MA State Medical License 1998 - 2009
- American Board of Internal Medicine Nephrology
Clinical Trials
- HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Start of enrollment: 2020 Mar 13
Publications & Presentations
PubMed
- Intravenous iron-induced hypophosphatemia and kidney stone disease.Marlene Panzer, Eva Meindl, Benedikt Schaefer, Sonja Wagner, Bernhard Glodny, Gert Mayer, Andreas Pircher, Christoph Schwarz, Felix Beckmann, Clivia Hejny, Bastian Joa...> ;Bone Reports. 2024 Jun 1
- Klotho and Clinical Outcomes in CKD.Michaela A A Fuchs, Emily J Burke, , Daniel Edmonston, Tamara Isakova, Myles Wolf> ;American Journal of Kidney Diseases. 2024 Apr 5
- Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with Chronic Kidney Disease.Jacquelyn Trujillo, Manal Alotaibi, Nay Seif, Xuan Cai, Brett Larive, Jennifer Gassman, Kalani L Raphael, Alfred K Cheung, Dominic S Raj, Linda F Fried, Stuart Sprague...> ;Kidney360. 2024 Apr 4
- Join now to see all
Press Mentions
- New Kidney Function Test Takes Race Out of the EquationSeptember 23rd, 2021
- Clinical Trial Sheds New Light on Potential Risk Associated with Intravenous Iron TreatmentDecember 6th, 2018
- Etelcalcetide Reduces PTH Levels in Moderate to Severe SHPTJanuary 11th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: